This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Buck Institute for Research on Aging, Napa Therapeutics Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 51 
1 out of 1 Years Active: 2025
Title: Elena Silva: Innovator in CD38 Inhibition
Introduction
Elena Silva is a prominent inventor based in Novato, CA (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of inhibitors for CD38. Her innovative work has the potential to impact the treatment of various diseases and disorders.
Latest Patents
Elena Silva holds a patent for "Heteroaryl amide inhibitors of CD38." This patent discloses heteroaryl amide inhibitors of CD38 and outlines methods for making and using these compounds in the treatment of diseases and disorders. She has 1 patent to her name, showcasing her expertise and dedication to advancing medical science.
Career Highlights
Throughout her career, Elena has worked with notable organizations, including Napa Therapeutics Limited and the Buck Institute for Research on Aging. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Elena has collaborated with esteemed colleagues such as Robert A. Volkmann and Jotham W. Coe. These partnerships have enriched her research and expanded the impact of her work in the scientific community.
Conclusion
Elena Silva is a remarkable inventor whose work in CD38 inhibition is paving the way for new therapeutic approaches. Her contributions to medicinal chemistry and her collaborations with other experts highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile